Top Markets
Coin of the day
CardioGenics Holdings Inc CardioGenics Holdings Inc

CardioGenics Holdings Inc

CGNH
株式のランク #41819
CardioGenics Holdings Inc. focuses on the creation and global distribution of... CardioGenics Holdings Inc. focuses on the creation and global distribution of diagnostic testing solutions within the in vitro diagnostics (IVD) sector, serving markets across the United States, Canada, Europe, and other international regions. A key offering is the QL Care Analyzer, an automated, self-contained, and portable point-of-care (POC) immunoassay device. This analyzer utilizes a unique, patented self-metering cartridge to perform immunoassay evaluations directly at the point of care. The company also provides a range of immunoassay panels specifically engineered to detect cardiac biomarkers in blood, which is vital for identifying heart attacks. Additionally, CardioGenics supplies paramagnetic beads, serving as crucial solid supports in heterogeneous immunoassay procedures for both clinical and research institutions. Established in 1997, the company was initially known as Jag Media Holdings, Inc. before officially changing its name to CardioGenics Holdings Inc. in 2009. Its corporate headquarters are situated in Mississauga, Canada.
株価
$0.0001
最終同期: 2026-08-11
時価総額
$9.61K
変化(1日)
0.00%
変化(1年)
0.00%
CA
取引 CardioGenics Holdings Inc (CGNH)

カテゴリー

CardioGenics Holdings Inc(CGNH)の利益
2026 時点の利益 TTM: 0
CardioGenics Holdings Inc の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
CardioGenics Holdings Inc の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益